| Apr 4 2023 |
Lawsuit Forces Early Release of NTP’s Draft Report on Fluoride, and its Potential Association with Neurodevelopment and Cognition |
ArentFox Schiff LLP |
| Apr 4 2023 |
White House Report Identifies Precision Medicine for Future R & D Investment |
Foley & Lardner LLP |
| Apr 4 2023 |
FDA Holds Joint Meeting on Food Safety with Mexican Counterparts |
Keller and Heckman LLP |
| Apr 3 2023 |
White House OSTP Outlines Goals for U.S. Biotechnology and Manufacturing |
Bergeson & Campbell, P.C. |
| Apr 3 2023 |
Editors’ Roundtable: Predictions About the Upcoming Farm Bill |
Bradley Arant Boult Cummings LLP |
| Apr 3 2023 |
FDA Publishes Framework for Digital Health Technologies in Clinical Trials |
Foley & Lardner LLP |
| Apr 3 2023 |
EPA Proposes National Primary Drinking Water Regulation to Set Stringent Limits on PFAS in Drinking Water, Including Four Newly Targeted Substances |
Hunton Andrews Kurth |
| Apr 3 2023 |
New Lawsuit Comes Amidst Push to Exclude Juice From “Healthy” Definition |
Keller and Heckman LLP |
| Mar 31 2023 |
McDermott+Consulting Check-Up: March 31, 2023 |
McDermott Will & Schulte LLP |
| Mar 31 2023 |
New Cosmetics Regulatory Scheme to Reshape Industry's Relationship with FDA |
McDermott Will & Schulte LLP |
| Mar 30 2023 |
Medical Device Developers Now Required to Incorporate Cybersecurity Plans into FDA Premarket Submissions for “Cyber” Devices |
Mintz |
| Mar 30 2023 |
Food and Chemicals Unpacked: Laying Claim: FTC’s Green Guides |
Keller and Heckman LLP |
| Mar 30 2023 |
Use of Salt Substitutes Expanded to Help Lower Sodium Intake |
Keller and Heckman LLP |
| Mar 30 2023 |
The South Korean Food Authority Releases New Rules and Policies Supporting the Development of the Alternative Protein Industry |
Keller and Heckman LLP |
| Mar 30 2023 |
The Short-Term Consequences of Alabama’s Cannabis Social Equity Policy |
Bradley Arant Boult Cummings LLP |
| Mar 29 2023 |
FDA Publishes Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market |
Keller and Heckman LLP |
| Mar 29 2023 |
FDA Issues First Untitled Letter of the Year to HCT/P Manufacturer |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 29 2023 |
The BioPharma Patent Cliff: 2023 and Beyond |
Foley & Lardner LLP |
| Mar 28 2023 |
FDA Revamps Guidance Concerning Use of Electronic Systems, Records, and Signatures in Clinical Investigations |
Nelson Mullins |
| Mar 28 2023 |
De-scheduling vs. Re-scheduling Marijuana: A Dramatic Difference |
Bradley Arant Boult Cummings LLP |
| Mar 28 2023 |
FSIS Proposes New Rules Regarding U.S. Origin Claims |
Keller and Heckman LLP |
| Mar 28 2023 |
Weeding Out Employees: The Ups and Downs of Drug-Testing Manufacturing Workforce |
Jackson Lewis P.C. |
| Mar 28 2023 |
Technical Effect Embodied In Technical Teaching |
K&L Gates LLP |
| Mar 27 2023 |
FDA Issues Draft Guidance on Dietary Guidance Statements on Food Labels |
Keller and Heckman LLP |
| Mar 27 2023 |
Last Dance with Mary Jane? Faltering Cannabis Businesses May Have a Bankruptcy Option in Addition to State Law Remedies |
Bradley Arant Boult Cummings LLP |
| Mar 25 2023 |
EC Committee Issues Final Opinion on Hydroxyapatite (Nano) in Oral Cosmetic Products |
Bergeson & Campbell, P.C. |
| Mar 24 2023 |
Judge Approves $25M Settlement of Antitrust Action Against J&J for Allegedly Blocking Biosimilars |
MoginRubin |
| Mar 24 2023 |
Pfizer Expands Cancer Drug Portfolio with $43 Billion Biotech Acquisition |
MoginRubin |
| Mar 23 2023 |
APHIS Accepting Public Comments on Draft Guide for Submitting Permit Applications for Microorganisms Developed using Genetic Engineering |
Bergeson & Campbell, P.C. |
| Mar 23 2023 |
California Assembly Members Introduce Bill to Ban Certain Color Additives |
Keller and Heckman LLP |
| Mar 23 2023 |
FDA Revises Recommendations Regarding Electronic Systems, Records, and Signatures in Clinical Investigations |
Nelson Mullins |
| Mar 23 2023 |
Is the Access to Medical Marijuana a Fundamental Right? |
Bradley Arant Boult Cummings LLP |
| Mar 22 2023 |
Big Law Redefined: Episode 3 | Beauty Trends in a Post-Pandemic World [PODCAST] |
Greenberg Traurig, LLP |
| Mar 22 2023 |
Recent Employment Law Updates in the District of Columbia |
Mintz |
| Mar 22 2023 |
This Week in 340B: March 14 – 20, 2023 |
McDermott Will & Schulte LLP |
